This week on Contemporary OB/GYN®: Aug 29 to Sept 2


What's coming to Contemporary OB/GYN® this week?

In-utero opioid exposure increases risk of neonatal opioid withdrawal syndrome

Investigators found that opioid use during pregnancy increases the relative risk of neonatal opioid withdrawal syndrome in newborns.

Antenatal corticosteroid treatment associated with psychological developmental disorders

Researchers have found that maternal antenatal corticosteroid treatment can lead to increased risk of psychological developmental and neurosensory disorders in children.

Contemporary OB/GYN®: September 2022 Edition

This month's issue focuses on barriers and access to care, from emergency contraception to reproductive care in adolescents with disabilities. Stay up to date on the latest guidelines and recommendations for monkeypox in pregnancy. Plus, get a recap of what you missed at ASCO 2022.

Inclusion is not erasure: Antitransgender discourse reinforces attacks on reproductive rights

This month's guest editorial features perspectives from Drs. Frances Grimstad, Elizabeth Bosky, and Jessica Kremen of the landscape of inclusion in health care.

Improving contraceptive care for marginalized populations

Consider the needs of marginalized patients to promote equity.

Updates on emergency contraception

Nearly half (45%) of all pregnancies in the United States from 2015 to 2019 were unintended. Unfortunately, patients are likely to receive inaccurate information about emergency contraceptive pills from retail pharmacies, and significant gaps exist in training and knowledge of emergency contraception among ob-gyn and family medicine residents.

Check back soon for additional updates.

Related Videos
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit:
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit:
Navigating vasomotor symptoms in breast cancer patients | Image Credit:
Fertility counseling for oncology patients | Image Credit:
Learning what women prefer in STI preventive care
Related Content
© 2024 MJH Life Sciences

All rights reserved.